Irvine, CA, United States of America

Mingting Tian

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Mingting Tian

Introduction

Mingting Tian is a notable inventor based in Irvine, CA, who has made significant contributions to the field of medical treatments, particularly concerning retinal diseases. With a total of two patents to his name, Tian's work focuses on innovative methods that aim to improve patient outcomes.

Latest Patents

Mingting Tian's latest patents include groundbreaking methods for treating diseases of the retina. One of the disclosed methods involves administering a compound selected from a group that includes olanzapine, certain of its metabolites, clozapine, and n-desmethyl clozapine to patients in need of such treatment. This innovative approach highlights his commitment to advancing medical science and improving therapeutic options for patients suffering from retinal disorders.

Career Highlights

Throughout his career, Mingting Tian has been associated with Allergan, Inc., a leading company in the pharmaceutical industry. His work at Allergan has allowed him to focus on developing effective treatments that address critical health issues, particularly in ophthalmology.

Collaborations

Mingting Tian has collaborated with several talented individuals in his field, including Jyotirmoy Kusari and Sheila X Zhou. These collaborations have likely contributed to the innovative nature of his work and the successful development of his patents.

Conclusion

Mingting Tian's contributions to the field of retinal disease treatment through his patents reflect his dedication to innovation and improving patient care. His work continues to inspire advancements in medical treatments, showcasing the importance of research and collaboration in the pursuit of better health solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…